Innovative digital application predicts bilirubin, the biomarker for neonatal jaundice, helping to enhance early intervention and care TELFORD, Penn., March 24, 2025 /PRNewswire/ -- Dräger is ...
Objectives: To analyse if the currently used jaundice action charts are evidence based. Methods: We contacted 72 neonatal units in the Great Britain and enquired about the unit guidelines for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback